Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Review

Extrachromosomal circular DNA: a new potential role in cancer progression

Authors: Tianyi Wang, Haijian Zhang, Youlang Zhou, Jiahai Shi

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Extrachromosomal circular DNA (eccDNA) is considered a circular DNA molecule that exists widely in nature and is independent of conventional chromosomes. eccDNA can be divided into small polydispersed circular DNA (spcDNA), telomeric circles (t-circles), microDNA, and extrachromosomal DNA (ecDNA) according to its size and sequence. Multiple studies have shown that eccDNA is the product of genomic instability, has rich and important biological functions, and is involved in the occurrence of many diseases, including cancer. In this review, we focus on the discovery history, formation process, characteristics, and physiological functions of eccDNAs; the potential functions of various eccDNAs in human cancer; and the research methods employed to study eccDNA.
Literature
1.
2.
3.
Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ Clin Res. 2020;370:m2200.
4.
5.
Cox D, Yuncken C, Spriggs A. Minute chromatin bodies in malignant tumours of childhood. Lancet. 1965;1:55–8.PubMedCrossRef
6.
Gaubatz J. Extrachromosomal circular DNAs and genomic sequence plasticity in eukaryotic cells. Mutat Res. 1990;237:271–92.PubMedCrossRef
7.
Cohen S, Regev A, Lavi S. Small polydispersed circular DNA (spcDNA) in human cells: association with genomic instability. Oncogene. 1997;14:977–85.PubMedCrossRef
8.
9.
Dillon L, Kumar P, Shibata Y, Wang Y, Willcox S, Griffith J, Pommier Y, Takeda S, Dutta A. Production of extrachromosomal MicroDNAs is linked to mismatch repair pathways and transcriptional activity. Cell Rep. 2015;11:1749–59.PubMedPubMedCentralCrossRef
10.
Kumar P, Dillon L, Shibata Y, Jazaeri A, Jones D, Dutta A. Normal and cancerous tissues release extrachromosomal circular DNA (eccDNA) into the circulation. Mol Cancer Res. 2017;15:1197–205.PubMedPubMedCentralCrossRef
11.
12.
Liao Z, Jiang W, Ye L, Li T, Yu X, Liu L. Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression. Biochimica et biophysica acta Reviews on cancer. 2020;1874:188392.PubMedCrossRef
13.
Ain Q, Schmeer C, Wengerodt D, Witte O, Kretz A. Extrachromosomal circular DNA: current knowledge and implications for CNS aging and neurodegeneration. Int J Mol Sci. 2020;21:2477.PubMedCentralCrossRef
14.
15.
Sinclair J, Stevens B, Sanghavi P, Rabinowitz M. Mitochondrial-satellite and circular DNA filaments in yeast. Science. 1967;156:1234–7.PubMedCrossRef
16.
Shapiro L, Grossman L, Marmur J, Kleinschmidt A. Physical studies on the structure of yeast mitochondrial DNA. J Mol Biol. 1968;33:907–22.PubMedCrossRef
17.
Radloff R, Bauer W, Vinograd J. A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells. Proc Natl Acad Sci USA. 1967;57:1514–21.PubMedCrossRefPubMedCentral
18.
19.
Møller H, Parsons L, Jørgensen T, Botstein D, Regenberg B. Extrachromosomal circular DNA is common in yeast. Proc Natl Acad Sci USA. 2015;112:E3114-3122.PubMedCrossRefPubMedCentral
20.
Stanfield S, Lengyel J. Small circular DNA of Drosophila melanogaster: chromosomal homology and kinetic complexity. Proc Natl Acad Sci USA. 1979;76:6142–6.PubMedCrossRefPubMedCentral
21.
Sunnerhagen P, Sjöberg R, Karlsson A, Lundh L, Bjursell G. Molecular cloning and characterization of small polydisperse circular DNA from mouse 3T6 cells. Nucleic Acids Res. 1986;14:7823–38.PubMedPubMedCentralCrossRef
22.
Alt F, Kellems R, Bertino J, Schimke R. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem. 1978;253:1357–70.PubMedCrossRef
23.
Kohl N, Kanda N, Schreck R, Bruns G, Latt S, Gilbert F, Alt F. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell. 1983;35:359–67.PubMedCrossRef
24.
25.
Shibata Y, Kumar P, Layer R, Willcox S, Gagan J, Griffith J, Dutta A. Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues. Science. 2012;336:82–6.PubMedPubMedCentralCrossRef
26.
Nathanson D, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, Eskin A, Hwang K, Wang J, Masui K, et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. 2014;343:72–6.PubMedCrossRef
27.
Turner K, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson D, et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017;543:122–5.PubMedPubMedCentralCrossRef
28.
Møller H, Mohiyuddin M, Prada-Luengo I, Sailani M, Halling J, Plomgaard P, Maretty L, Hansen A, Snyder M, Pilegaard H, et al. Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. Nat Commun. 2018;9:1069.PubMedPubMedCentralCrossRef
29.
Wu S, Turner K, Nguyen N, Raviram R, Erb M, Santini J, Luebeck J, Rajkumar U, Diao Y, Li B, et al. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature. 2019;575:699–703.PubMedPubMedCentralCrossRef
30.
Morton A, Dogan-Artun N, Faber Z, MacLeod G, Bartels C, Piazza M, Allan K, Mack S, Wang X, Gimple R, et al. Functional enhancers shape extrachromosomal oncogene amplifications. Cell. 2019;179:1330–41.PubMedPubMedCentralCrossRef
31.
Kunisada T, Yamagishi H, Ogita Z, Kirakawa T, Mitsui Y. Appearance of extrachromosomal circular DNAs during in vivo and in vitro ageing of mammalian cells. Mech Ageing Dev. 1985;29:89–99.PubMedCrossRef
32.
33.
Jones R, Potter S. L1 sequences in HeLa extrachromosomal circular DNA: evidence for circularization by homologous recombination. Proc Natl Acad Sci USA. 1985;82:1989–93.PubMedCrossRefPubMedCentral
34.
Varshavsky A. On the possibility of metabolic control of replicon “misfiring”: relationship to emergence of malignant phenotypes in mammalian cell lineages. Proc Natl Acad Sci USA. 1981;78:3673–7.PubMedCrossRefPubMedCentral
35.
Fujimoto S, Yamagishi H. Isolation of an excision product of T-cell receptor alpha-chain gene rearrangements. Nature. 1987;327:242–3.PubMedCrossRef
36.
Flavell A, Ish-Horowicz D. Extrachromosomal circular copies of the eukaryotic transposable element copia in cultured Drosophila cells. Nature. 1981;292:591–5.PubMedCrossRef
37.
Flavell A, Ish-Horowicz D. The origin of extrachromosomal circular copia elements. Cell. 1983;34:415–9.PubMedCrossRef
38.
39.
Cohen Z, Bacharach E, Lavi S. Mouse major satellite DNA is prone to eccDNA formation via DNA Ligase IV-dependent pathway. Oncogene. 2006;25:4515–24.PubMedCrossRef
40.
Cohen S, Lavi S. Induction of circles of heterogeneous sizes in carcinogen-treated cells: two-dimensional gel analysis of circular DNA molecules. Mol Cell Biol. 1996;16:2002–14.PubMedPubMedCentralCrossRef
41.
Shay J, Wright W. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20:299–309.PubMedCrossRef
42.
Nosek J, Dinouël N, Kovac L, Fukuhara H. Linear mitochondrial DNAs from yeasts: telomeres with large tandem repetitions. Mol Gen Genet MGG. 1995;247:61–72.PubMedCrossRef
43.
Tomaska L, Nosek J, Makhov A, Pastorakova A, Griffith J. Extragenomic double-stranded DNA circles in yeast with linear mitochondrial genomes: potential involvement in telomere maintenance. Nucleic Acids Res. 2000;28:4479–87.PubMedPubMedCentralCrossRef
44.
Perrem K, Colgin L, Neumann A, Yeager T, Reddel R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol. 2001;21:3862–75.PubMedPubMedCentralCrossRef
45.
Cesare A, Griffith J. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol. 2004;24:9948–57.PubMedPubMedCentralCrossRef
46.
Wang R, Smogorzewska A, de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell. 2004;119:355–68.PubMedCrossRef
47.
Laud P, Multani A, Bailey S, Wu L, Ma J, Kingsley C, Lebel M, Pathak S, DePinho R, Chang S. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 2005;19:2560–70.PubMedPubMedCentralCrossRef
48.
Sarkar J, Wan B, Yin J, Vallabhaneni H, Horvath K, Kulikowicz T, Bohr V, Zhang Y, Lei M, Liu Y. SLX4 contributes to telomere preservation and regulated processing of telomeric joint molecule intermediates. Nucleic Acids Res. 2015;43:5912–23.PubMedPubMedCentralCrossRef
49.
Vannier J, Pavicic-Kaltenbrunner V, Petalcorin M, Ding H, Boulton S. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell. 2012;149:795–806.PubMedCrossRef
50.
51.
McEachern M, Krauskopf A, Blackburn E. Telomeres and their control. Annu Rev Genet. 2000;34:331–58.PubMedCrossRef
52.
Tomaska L, McEachern M, Nosek J. Alternatives to telomerase: keeping linear chromosomes via telomeric circles. FEBS Lett. 2004;567:142–6.PubMedCrossRef
53.
Paulsen T, Shibata Y, Kumar P, Dillon L, Dutta A. Small extrachromosomal circular DNAs, microDNA, produce short regulatory RNAs that suppress gene expression independent of canonical promoters. Nucleic Acids Res. 2019;47:4586–96.PubMedPubMedCentralCrossRef
54.
Benner S, Wahl G, Von Hoff D. Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anticancer Drugs. 1991;2:11–25.PubMedCrossRef
55.
McGill J, Beitzel B, Nielsen J, Walsh J, Drabek S, Meador R, Von Hoff D. Double minutes are frequently found in ovarian carcinomas. Cancer Genet Cytogenet. 1993;71:125–31.PubMedCrossRef
56.
Gebhart E, Brüderlein S, Tulusan A, von Maillot K, Birkmann J. Incidence of double minutes, cytogenetic equivalents of gene amplification, in human carcinoma cells. Int J Cancer. 1984;34:369–73.PubMedCrossRef
57.
Rattner J, Lin C. Ultrastructural organization of double minute chromosomes and HSR regions in human colon carcinoma cells. Cytogenet Cell Genet. 1984;38:176–81.PubMedCrossRef
58.
Haaf T, Schmid M. Analysis of double minutes and double minute-like chromatin in human and murine tumor cells using antikinetochore antibodies. Cancer Genet Cytogenet. 1988;30:73–82.PubMedCrossRef
59.
Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7:233–45.PubMedCrossRef
60.
Fan Y, Mao R, Lv H, Xu J, Yan L, Liu Y, Shi M, Ji G, Yu Y, Bai J, et al. Frequency of double minute chromosomes and combined cytogenetic abnormalities and their characteristics. J Appl Genet. 2011;52:53–9.PubMedCrossRef
61.
McCLINTOCK B. Chromosome organization and genic expression. Cold Spring Harb Symp Quant Biol. 1951;16:13–47.PubMedCrossRef
62.
Vukovic B, Beheshti B, Park P, Lim G, Bayani J, Zielenska M, Squire J. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer. Cytogenet Genome Res. 2007;116:1–11.PubMedCrossRef
63.
Murnane J, Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. BioEssays. 2004;26:1164–74.PubMedCrossRef
64.
Barr F, Nauta L, Davis R, Schäfer B, Nycum L, Biegel J. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet. 1996;5:15–21.PubMedCrossRef
65.
Van Roy N, Vandesompele J, Menten B, Nilsson H, De Smet E, Rocchi M, De Paepe A, Påhlman S, Speleman F. Translocation-excision-deletion-amplification mechanism leading to nonsyntenic coamplification of MYC and ATBF1. Genes Chromosom Cancer. 2006;45:107–17.PubMedCrossRef
66.
Röijer E, Nordkvist A, Ström A, Ryd W, Behrendt M, Bullerdiek J, Mark J, Stenman G. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol. 2002;160:433–40.PubMedPubMedCentralCrossRef
67.
Carroll S, Gaudray P, De Rose M, Emery J, Meinkoth J, Nakkim E, Subler M, Von Hoff D, Wahl G. Characterization of an episome produced in hamster cells that amplify a transfected CAD gene at high frequency: functional evidence for a mammalian replication origin. Mol Cell Biol. 1987;7:1740–50.PubMedPubMedCentral
68.
Carroll S, DeRose M, Gaudray P, Moore C, Needham-Vandevanter D, Von Hoff D, Wahl G. Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol. 1988;8:1525–33.PubMedPubMedCentral
69.
Storlazzi C, Fioretos T, Surace C, Lonoce A, Mastrorilli A, Strömbeck B, D’Addabbo P, Iacovelli F, Minervini C, Aventin A, et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet. 2006;15:933–42.PubMedCrossRef
70.
Storlazzi C, Lonoce A, Guastadisegni M, Trombetta D, D’Addabbo P, Daniele G, L’Abbate A, Macchia G, Surace C, Kok K, et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 2010;20:1198–206.PubMedPubMedCentralCrossRef
71.
Stephens P, Greenman C, Fu B, Yang F, Bignell G, Mudie L, Pleasance E, Lau K, Beare D, Stebbings L, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27–40.PubMedPubMedCentralCrossRef
72.
Korbel J, Campbell P. Criteria for inference of chromothripsis in cancer genomes. Cell. 2013;152:1226–36.PubMedCrossRef
73.
Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson G, Connor A, Denroche R, Liang S, Brown A, Kim J, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. 2016;538:378–82.PubMedPubMedCentralCrossRef
74.
Molenaar J, Koster J, Zwijnenburg D, van Sluis P, Valentijn L, van der Ploeg I, Hamdi M, van Nes J, Westerman B, van Arkel J, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012;483:589–93.PubMedCrossRef
75.
Fraser M, Sabelnykova V, Yamaguchi T, Heisler L, Livingstone J, Huang V, Shiah Y, Yousif F, Lin X, Masella A, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017;541:359–64.PubMedCrossRef
76.
Rausch T, Jones D, Zapatka M, Stütz A, Zichner T, Weischenfeldt J, Jäger N, Remke M, Shih D, Northcott P, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell. 2012;148:59–71.PubMedPubMedCentralCrossRef
77.
George J, Lim J, Jang S, Cun Y, Ozretić L, Kong G, Leenders F, Lu X, Fernández-Cuesta L, Bosco G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47–53.PubMedPubMedCentralCrossRef
78.
Itoh N, Shimizu N. DNA replication-dependent intranuclear relocation of double minute chromatin. J Cell Sci. 1998;111:3275–85.PubMedCrossRef
79.
Shimizu N, Ochi T, Itonaga K. Replication timing of amplified genetic regions relates to intranuclear localization but not to genetic activity or G/R band. Exp Cell Res. 2001;268:201–10.PubMedCrossRef
80.
Lee D, Hayes J, Pruss D, Wolffe A. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993;72:73–84.PubMedCrossRef
81.
Sinclair D, Guarente L. Extrachromosomal rDNA circles–a cause of aging in yeast. Cell. 1997;91:1033–42.PubMedCrossRef
82.
83.
84.
Chen X, Shen Y, Draper W, Buenrostro J, Litzenburger U, Cho S, Satpathy A, Carter A, Ghosh R, East-Seletsky A, et al. ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing. Nat Methods. 2016;13:1013–20.PubMedPubMedCentralCrossRef
85.
86.
87.
88.
89.
Laver T, Harrison J, O’Neill P, Moore K, Farbos A, Paszkiewicz K, Studholme D. Assessing the performance of the Oxford Nanopore Technologies MinION. Biomolecular detection and quantification. 2015;3:1–8.PubMedPubMedCentralCrossRef
90.
Thompson J, Steinmann K. Single molecule sequencing with a HeliScope genetic analysis system. Curr Protocols Mol Biol. 2010;92:7–10.CrossRef
91.
Flusberg B, Webster D, Lee J, Travers K, Olivares E, Clark T, Korlach J, Turner S. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods. 2010;7:461–5.PubMedPubMedCentralCrossRef
92.
Kenrick K, Margolis J. Isoelectric focusing and gradient gel electrophoresis: a two-dimensional technique. Anal Biochem. 1970;33:204–7.PubMedCrossRef
93.
94.
Li L, Norman A, Hansen L, Sørensen S. Metamobilomics–expanding our knowledge on the pool of plasmid encoded traits in natural environments using high-throughput sequencing. Clin Microbiol Infect. 2012;18:5–7.PubMedCrossRef
95.
Brown Kav A, Sasson G, Jami E, Doron-Faigenboim A, Benhar I, Mizrahi I. Insights into the bovine rumen plasmidome. Proc Natl Acad Sci USA. 2012;109:5452–7.PubMedCrossRef
96.
97.
98.
99.
Gheldof N, Leleu M, Noordermeer D, Rougemont J, Reymond A. Detecting long-range chromatin interactions using the chromosome conformation capture sequencing (4C-seq) method. Methods Mol Biol. 2012;786:211–25.PubMedCrossRef
100.
van de Werken H, Landan G, Holwerda S, Hoichman M, Klous P, Chachik R, Splinter E, Valdes-Quezada C, Oz Y, Bouwman B, et al. Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods. 2012;9:969–72.PubMedCrossRef
101.
Fang R, Yu M, Li G, Chee S, Liu T, Schmitt A, Ren B. Mapping of long-range chromatin interactions by proximity ligation-assisted ChIP-seq. Cell Res. 2016;26:1345–8.PubMedPubMedCentralCrossRef
102.
Juric I, Yu M, Abnousi A, Raviram R, Fang R, Zhao Y, Zhang Y, Qiu Y, Yang Y, Li Y, et al. MAPS: Model-based analysis of long-range chromatin interactions from PLAC-seq and HiChIP experiments. PLoS Comput Biol. 2019;15:e1006982.PubMedPubMedCentralCrossRef
103.
Buenrostro J, Giresi P, Zaba L, Chang H, Greenleaf W. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213–8.PubMedPubMedCentralCrossRef
104.
Semenkovich N, Planer J, Ahern P, Griffin N, Lin C, Gordon J. Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes. Proc Natl Acad Sci USA. 2016;113:14805–10.PubMedCrossRefPubMedCentral
105.
Deshpande V, Luebeck J, Nguyen N, Bakhtiari M, Turner K, Schwab R, Carter H, Mischel P, Bafna V. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019;10:392.PubMedPubMedCentralCrossRef
106.
Luebeck J, Coruh C, Dehkordi S, Lange J, Turner K, Deshpande V, Pai D, Zhang C, Rajkumar U, Law J, et al. AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. Nat Commun. 2020;11:4374.PubMedPubMedCentralCrossRef
107.
Rajkumar U, Turner K, Luebeck J, Deshpande V, Chandraker M, Mischel P, Bafna V. EcSeg: semantic segmentation of metaphase images containing extrachromosomal DNA. iScience. 2019;21:428–35.PubMedPubMedCentralCrossRef
108.
Nguyen N, Deshpande V, Luebeck J, Mischel P, Bafna V. ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer. Nucleic Acids Res. 2018;46:3309–25.PubMedPubMedCentralCrossRef
109.
110.
Mehanna P, Gagné V, Lajoie M, Spinella J, St-Onge P, Sinnett D, Brukner I, Krajinovic M. Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines. PloS ONE. 2017;12:e0184365.PubMedPubMedCentralCrossRef
111.
Schwarzenbach H, Hoon D, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–37.PubMedCrossRef
112.
Regev A, Cohen S, Cohen E, Bar-Am I, Lavi S. Telomeric repeats on small polydisperse circular DNA (spcDNA) and genomic instability. Oncogene. 1998;17:3455–61.PubMedCrossRef
113.
Sin S, Ji L, Deng J, Jiang P, Cheng S, Heung M, Lau C, Leung T, Chan K, Chiu R, Lo Y. Characteristics of fetal extrachromosomal circular DNA in maternal plasma: methylation status and clearance. Clin Chem. 2021;67:788–96.PubMedCrossRef
114.
Helmsauer K, Valieva M, Ali S, Chamorro González R, Schöpflin R, Röefzaad C, Bei Y, Dorado Garcia H, Rodriguez-Fos E, Puiggròs M, et al. Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma. Nat Commun. 2020;11:5823.PubMedPubMedCentralCrossRef
115.
Koche R, Rodriguez-Fos E, Helmsauer K, Burkert M, MacArthur I, Maag J, Chamorro R, Munoz-Perez N, Puiggròs M, Dorado Garcia H, et al. Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma. Nat Genet. 2020;52:29–34.PubMedCrossRef
116.
Zhou Y, Chen Y, Hu Y, Yu L, Tran K, Giedzinski E, Ru N, Gau A, Pan F, Qiao J, et al. The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy. Oncotarget. 2017;8:80853–68.PubMedPubMedCentralCrossRef
117.
Nikolaev S, Santoni F, Garieri M, Makrythanasis P, Falconnet E, Guipponi M, Vannier A, Radovanovic I, Bena F, Forestier F, et al. Extrachromosomal driver mutations in glioblastoma and low-grade glioma. Nat Commun. 2014;5:5690.PubMedCrossRef
118.
Morales C, García M, Ribas M, Miró R, Muñoz M, Caldas C, Peinado M. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Mol Cancer Ther. 2009;8:424–32.PubMedCrossRef
119.
Meng X, Qi X, Guo H, Cai M, Li C, Zhu J, Chen F, Guo H, Li J, Zhao Y, et al. Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells. J Med Genet. 2015;52:135–44.PubMedCrossRef
120.
Jia X, Guan R, Cui X, Zhu J, Liu P, Zhang L, Wang D, Zhang Y, Dong K, Wu J, et al. Molecular structure and evolution mechanism of two populations of double minutes in human colorectal cancer cells. J Cell Mol Med. 2020;24:14205–16.PubMedPubMedCentralCrossRef
121.
Jin Y, Liu Z, Cao W, Ma X, Fan Y, Yu Y, Bai J, Chen F, Rosales J, Lee K, Fu S. Novel functional MAR elements of double minute chromosomes in human ovarian cells capable of enhancing gene expression. PloS ONE. 2012;7:e30419.PubMedPubMedCentralCrossRef
122.
Vicario R, Peg V, Morancho B, Zacarias-Fluck M, Zhang J, Martínez-Barriocanal Á, Navarro Jiménez A, Aura C, Burgues O, Lluch A, et al. Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies. PloS one 2015;10:e0129876.
123.
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13:45.PubMedPubMedCentralCrossRef
124.
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8:761–73.PubMedPubMedCentralCrossRef
125.
Fabbri M. MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philos Trans Royal Soc London Series B Biol Sci. 2018;373:20160486.CrossRef
126.
127.
128.
Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller L, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973–80.PubMedPubMedCentralCrossRef
129.
130.
Kalaora S, Nagler A, Nejman D, Alon M, Barbolin C, Barnea E, Ketelaars S, Cheng K, Vervier K, Shental N, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592:138–43.PubMedCrossRef
131.
Riemer A. Bacterial peptides presented on tumour cells could be immunotherapy targets. Nature. 2021;592:28–9.CrossRef
Metadata
Title
Extrachromosomal circular DNA: a new potential role in cancer progression
Authors
Tianyi Wang
Haijian Zhang
Youlang Zhou
Jiahai Shi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-02927-x

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue

Research

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

Research

Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case–control study

Research

N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis

Research

MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis

Research

Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis

Research

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits